# Does Psilocybin Change Synaptic Density in Amnestic Mild Cognitive Impairment

> **NCT06041152** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Centre for Addiction and Mental Health** · enrollment: 10 (actual)

## Conditions studied

- Amnestic Mild Cognitive Impairment

## Interventions

- **DRUG:** Psilocybin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06041152
- **Lead sponsor:** Centre for Addiction and Mental Health
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-11-27
- **Primary completion:** 2026-07
- **Final completion:** 2026-07
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2026-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06041152

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06041152, "Does Psilocybin Change Synaptic Density in Amnestic Mild Cognitive Impairment". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06041152. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*